KEI statement on GSK’s announcement of policies to expand access to patented medicines
GSK has made a major announcement of new policies to expand access to its patented medicines. A copy of the press statement is here. Continue Reading
Intellectual Property Rights
2018: USTR report chastises India for “vocal encouragement and propagation” of policies that erode IPRs
In March 2018, the Office of the United States Trade Representative (USTR) published its 2018 National Trade Estimate Report on Foreign Trade Barriers (NTE). Every year, the USTR is mandated to “submit to the President,the Senate Finance Committee, and appropriate… Continue Reading
KEI requests that federal government use compulsory licenses on Kaléo held patents for devices used to administer opioid overdose reversal drug
KEI has submitted a request to Mr. James Carroll, Acting Director of the Office of National Drug Control Policy, and to Ms. Kellyanne Conway, Counselor to the President and appointed “opioid czar,” asking that the federal government use its authority… Continue Reading
EC publishes report on protection and enforcement of intellectual property rights in “third countries”
On March 12, 2018, the European Commission issued a press release on a report on the “protection and enforcement of intellectual property rights in third countries”. The report was published on February 21, 2018 and is entitled – “Commission Staff… Continue Reading
Coalition calls on US and Korea Trade Negotiators to prioritize public health over pharma corporations in trade negotiations
FOR IMMEDIATE RELEASE March 12, 2018 kim.treanor@keionline.org (202)-332-2670 A coalition of 16 advocacy organizations in the United States and Korea asked trade negotiators in the U.S. and Korea to reject the demands of the pharmaceutical industry, protect human rights, and… Continue Reading
Statement of Portugal: UN briefing on Promoting Innovation and Access to Health Technologies in the Context of the Agenda 2030
On Tuesday, 6 March 2018, Cristina Pucarinho, the Deputy Permanent Representative of Portugal to the United Nations made the following intervention at a UN briefing on Promoting Innovation and Access to Health Technologies in the Context of the Agenda 2030… Continue Reading
Compulsory licensing as a limitation on availability of injunctions under eBay doctrine.
Cases (currently being updated) 2017 Kaneka Corp. v. SKC Kolon PI, Inc., No. EDCV113397JGBRZX, 2017 WL 6343537 (C.D. Cal. Dec 8, 2017). Infringement case involving patents for polyimide films; motion for permanent injunction denied. Amgen Inc. v. Sanofi, 872 F.3d… Continue Reading
WTO TRIPS Council (February 2018): South Africa’s statement on the regulatory review exception
On Tuesday, 27 February 2018, the representative of the Republic of South Africa delivered the following statement at the World Trade Organization’s TRIPS Council; South Africa delivered this statement under the agenda item on IP and the Public Interest: Regulatory… Continue Reading
SCP 25
December 12 to December 15, 2016 WIPO’s Page on the Meeting SCP 25: Opening statement of Knowledge Ecology International SCP25: Statement of Asia Pacific Group on Patents and Health SCP25: South Africa’s Experience Related to the Topic of Access to… Continue Reading
Compensation under 28 USC §1498
More on 1498 here: https://www.keionline.org/cl/28usc1498 There is a discussion of compensation under 28 USC §1498 in Remuneration Guidelines for Non-Voluntary Use of a Patent on Medical Technologies. UNDP and World Health Organization. 2005 (pages 18-21 in the UNDP edition, and… Continue Reading
SCP 27
December 11 to December 15, 2017 WIPO’s Page for the Meeting SCP27: WIPO patent committee agrees to future work on patent oppositions, exceptions and limitations, and patents and health SCP27: South Africa urges WIPO to invite UNHLP Co-Chairs to present… Continue Reading